Prenatal diagnosis of succinic semialdehyde dehydrogenase deficiency: increased accuracy employing DNA, enzyme, and metabolite analyses
- PMID: 11243727
- DOI: 10.1006/mgme.2000.3145
Prenatal diagnosis of succinic semialdehyde dehydrogenase deficiency: increased accuracy employing DNA, enzyme, and metabolite analyses
Abstract
Inherited succinic semialdehyde dehydrogenase (SSADH; EC1.2.1.24; McKusick 271980) deficiency is a defect of GABA degradation which leads to accumulation of 4-hydroxybutyric acid (gamma-hydroxybutyric acid; GHB) in physiologic fluids of patients. Prenatal diagnosis (PND) was performed in three at-risk pregnancies employing combinations of: (1) reverse-transcription-polymerase chain reaction (RT-PCR) and genomic DNA amplification followed by sequencing using isolated leukocytes or cultured human lymphoblasts; (2) GHB quantitation in amniotic fluid; or (3) SSADH enzyme assay in chorionic villus (CV) and/or amniocytes. In two pregnancies, all analyses were concordant for prediction of disease status in the fetus. In the third case, enzyme activity in CV (deficient) and metabolite analysis in amniotic fluid (normal) were discordant. For clarification, mutation analysis was undertaken in CV, confirming heterozygosity for the mutation previously identified in the proband. We hypothesize that delayed transit time for shipment of CV between Greece and the United States (8 days) led to enhanced degradation of heterozygous SSADH enzyme activity. Our data demonstrate the importance of combined metabolite, enzyme, and DNA analysis for increased accuracy in the PND of SSADH deficiency.
Copyright 2001 Academic Press.
Similar articles
-
Photosensitive absence epilepsy with myoclonias and heterozygosity for succinic semialdehyde dehydrogenase (SSADH) deficiency.Clin Neurophysiol. 2004 Jun;115(6):1417-22. doi: 10.1016/j.clinph.2004.01.002. Clin Neurophysiol. 2004. PMID: 15134710
-
Pre- and postnatal diagnosis of succinic semialdehyde dehydrogenase deficiency using enzyme and metabolite assays.J Inherit Metab Dis. 1994;17(6):732-7. doi: 10.1007/BF00712016. J Inherit Metab Dis. 1994. PMID: 7707697
-
Vigabatrin and newer interventions in succinic semialdehyde dehydrogenase deficiency.Ann Neurol. 2003;54 Suppl 6:S66-72. doi: 10.1002/ana.10626. Ann Neurol. 2003. PMID: 12891656 Review.
-
Murine succinate semialdehyde dehydrogenase deficiency.Ann Neurol. 2003;54 Suppl 6:S81-90. doi: 10.1002/ana.10625. Ann Neurol. 2003. PMID: 12891658 Review.
-
Absence seizures in succinic semialdehyde dehydrogenase deficient mice: a model of juvenile absence epilepsy.Pharmacol Biochem Behav. 2004 Nov;79(3):547-53. doi: 10.1016/j.pbb.2004.09.008. Pharmacol Biochem Behav. 2004. PMID: 15582027
Cited by
-
Prenatal diagnosis of succinate semialdehyde dehydrogenase deficiency in non-identical twins.J Inherit Metab Dis. 2002 Oct;25(6):517-8. doi: 10.1023/a:1021215605013. J Inherit Metab Dis. 2002. PMID: 12555945
-
Inherited disorders of gamma-aminobutyric acid metabolism and advances in ALDH5A1 mutation identification.Dev Med Child Neurol. 2015 Jul;57(7):611-617. doi: 10.1111/dmcn.12668. Epub 2014 Dec 29. Dev Med Child Neurol. 2015. PMID: 25558043 Free PMC article. Review.
-
Disorders of GABA metabolism: SSADH and GABA-transaminase deficiencies.J Pediatr Epilepsy. 2014 Nov 25;3(4):217-227. doi: 10.3233/PEP-14097. J Pediatr Epilepsy. 2014. PMID: 25485164 Free PMC article.
-
Succinic semialdehyde dehydrogenase deficiency: a metabolic and genomic approach to diagnosis.Front Genet. 2024 Jun 19;15:1405468. doi: 10.3389/fgene.2024.1405468. eCollection 2024. Front Genet. 2024. PMID: 39011401 Free PMC article.
-
Understanding the Molecular Mechanisms of Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD): Towards the Development of SSADH-Targeted Medicine.Int J Mol Sci. 2022 Feb 26;23(5):2606. doi: 10.3390/ijms23052606. Int J Mol Sci. 2022. PMID: 35269750 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases